comparemela.com

Latest Breaking News On - சிகிச்சை சந்தை முன்னறிவிப்பு - Page 3 : comparemela.com

Global Allergy Treatment Markets, 2020-2021 & Forecast to 2028: Increasing Adoption of Immunotherapy in Allergy Treatment & Developments in Food Allergy Treatments

Share this article Share this article ResearchAndMarkets.com s offering. The global allergy treatment market is expected to reach US$ 35,812.33 million by 2028 from US$ 21,160.92 million in 2020; it is estimated to grow at a CAGR of 6.9% from 2020 to 2028. Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments are the factors driving the global allergy treatment market growth. However, the lack of awareness about allergies and their treatments are hindering the market growth. The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. Dust mite, animal dander, cockroach, pollens, mold, food substances, and metal and element particles are among the common allergens. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection aga

Global Peptide Therapeutics Market Report 2020-2027: SPPS, LPPS, Hybrid - Emphasis on Automatic Peptide Synthesis Gaining Momentum

Generic Segment to Grow at Faster Pace during Forecast Period Peptide Therapeutics Market is expected to reach US$ 50,003.15 million by 2027 from US$ 24,878.55 million in 2019; it is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the market growth. On the basis of type, the peptide therapeutics market is segmented into innovative and generic. The innovative segment held a larger share of the market in 2019; however, the generic segment is expected to register a higher CAGR during the forecast period. Rising number of research collaborations amongst market players are estimated to offer favorable environment for growth of gen

Worldwide Cell Therapy Industry to 2027 - Increasing Prevalence of Chronic Diseases is Driving the Market

Share this article Share this article ResearchAndMarkets.com s offering. According to this report the global cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. It is estimated to grow at a CAGR of 7.2% from 2020-2027. The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market. The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.

Insights on the Malaria Treatment Global Market to 2027 -by Treatment Type, Route of Administration, End-user and Geography

Insights on the Malaria Treatment Global Market to 2027 -by Treatment Type, Route of Administration, End-user and Geography
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.